Literature DB >> 19439042

The cardiac force-frequency relationship and frequency-dependent acceleration of relaxation are impaired in lipopolysaccharide-treated rats: is the phospholamban-SERCA axis a therapeutic target?

Stephen B Heitner1, Steven M Hollenberg.   

Abstract

Sepsis-induced myocardial dysfunction has traditionally been thought of as principally affecting systolic heart function. One of the primary reasons for this concept is that systolic dysfunction is relatively easy to conceptualize, visualize, and measure. With the advent of preload-independent measurements for diastolic function, both measurement and conceptual difficulties are being resolved, and a new realm of evidence is beginning to emerge regarding the aberrations that are found during cardiac relaxation in sepsis. A recent article in Critical Care brings this issue into sharper focus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439042      PMCID: PMC2689476          DOI: 10.1186/cc7752

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


In the previous issue of Critical Care, Joulin and colleagues [1] describe an animal model of lipopolysaccharide (LPS)-induced impaired myocardial systolic and diastolic function. Diastole is composed of two physiological phenomena: myocardial stiffness, which is energy independent, and active relaxation, which is an ATP-requiring process [2]. Current echocardiographic techniques can help distinguish which of the two is the predominant pathway, although these techniques may not always be practical in critically ill patients [3]. In some patients with sepsis, a reversible component to impaired ventricular relaxation has been demonstrated [4], which would imply that the energy-requiring component of diastolic function is more perturbed in certain patients. One might wonder why this is an important distinction to make, but considering that increased mortality in sepsis may be correlated with increasing fluid administration [5], it would seem that being able to distinguish between isolated systolic, diastolic, or combined dysfunction may prove to be life saving. In addition, therapeutic measures might reasonably be aimed at active relaxation. Isolated and reversible left ventricular diastolic dysfunction was recently demonstrated in septic patients [4]. This was achieved by serial transesophageal echocardiographic measurement of standard indices of systolic function, as well as analyzing diastolic mitral inflow and annular tissue Doppler patterns, the current standard in echocardiographic grading of diastolic function [4]. This study highlighted the fact that we should be cognizant that not all patients suffering from sepsis and shock should be treated uniformly, and that choices of intravenous resuscitation and vasopressor therapies need careful consideration. The study further elucidated the reversible nature of the impaired ventricular relaxation in humans, suggesting that a metabolic or molecular process may be responsible. Considerable work has been done on defining the molecular biology of diastole. An attractive mechanism currently thought to play a major role is that of calcium flux. Systole is initiated by rapid elevation of myocyte intracellular calcium, both through influx (through L-type calcium channels) and calcium-mediated calcium release from the sarcoplasmic reticulum (through the ryanodine receptor) [6]. Calcium itself then initiates conformational changes in the contractile apparatus that mediates contraction. Re-uptake of calcium into the sarcoplasmic reticulum by sarcoplasmic reticulum Ca2+-ATPase (SERCA) allows for cardiac relaxation. The ability of SERCA to pump calcium back into the sarcoplasmic reticulum is governed by phospholamban, a sarcoplasmic reticulum membrane-bound modulatory protein [7]. The rapidity at which calcium is returned to the sarcoplasmic reticulum is directly related to the rapidity of cardiac relaxation. In the unphosphorylated state, phospholamban inhibits calcium uptake by SERCA, and subsequently slows diastole. Signaling by protein kinase leads to phosphorylation of phospholamban, which, in turn, diminishes its inhibitory activity on SERCA, promoting cardiac relaxation. In a knockout mouse model lacking phospholamban, SERCA activity is uninhibited, and diastolic dysfunction with aging is not seen [8]. While other pathways, such as sodium-calcium exchange, are important in myocardial calcium trafficking, those are currently beyond the scope of this comment, and will not be described. Joulin and colleagues, in their experiments, were able to demonstrate a SERCA-dependent aberration in diastolic cardiomyocyte behavior. In particular, in their experiments, they were able to demonstrate a SERCA-dependent aberration in diastolic cardiomyocyte behavior. The force-frequency relationship (that is, heart-rate-dependent increase in cardiomyocyte shortening) and frequency-dependent acceleration of relaxation are physiological phenomena that ensure maintenance of cardiac output with the decreased ejection and filling times that are consequences of higher heart rates. The group hypothesized that LPS would disrupt this delicate balance by exerting an effect on the molecular workings within the cardiomyocyte – principally through the inhibition of the phosphorylation of phospholamban. By utilizing echocardiographic measurements of diastole, and through western blot analyses, they were able to demonstrate a correlation between LPS-induced myocardial relaxation dysfunction (frequency-dependent acceleration of relaxation depression) and SERCA function. It is important to note that this work was done in a murine model of LPS infusion, a model with potentially important differences from septic patients being treated in the intensive care unit [9]. It is well known that the mediators of the sepsis syndrome are numerous. Anesthetic agents were used to regulate heart rates, and real-time alterations in physiological functioning may have been missed. The group studied only the sarcoplasmic reticulum when calcium trafficking is also linked to mitochondrial function and integrity, nitric oxide production, the beta-adrenergic response, and potential protective effects on the myocardium during prolonged sepsis [10]. Would specific targeting of intracellular calcium, or SERCA-related protein kinase and phosphatase result in better hemodynamics in septic shock? There is already a body of evidence to suggest that calcium-sensitizing agents, such as levosimendan, may improve hemodynamics in sepsis. In two animal models, left ventricular relaxation was improved after treatment with levosimendan in contrast to inotropes, such as milrinone or dobutamine [11,12], and in a clinical trial, levosimendan proved useful in improving global hemodynamic measurements [13]. The study by Joulin and colleagues is certainly thought provoking, and will hopefully lead us closer to developing better strategies for dealing with sepsis-induced myocardial dysfunction – both its systolic and diastolic components.

Abbreviations

LPS: lipopolysaccharide; SERCA: sarcoplasmic reticulum Ca2+-ATPase.

Competing interests

The authors declare that they have no competing interests.
  13 in total

Review 1.  Cardiac excitation-contraction coupling.

Authors:  Donald M Bers
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

Review 2.  Clinical practice. Diastolic heart failure.

Authors:  Gerard P Aurigemma; William H Gaasch
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

Review 3.  Mouse models of resuscitated shock.

Authors:  Steven M Hollenberg
Journal:  Shock       Date:  2005-12       Impact factor: 3.454

4.  Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.

Authors:  Andrea Morelli; Stefano De Castro; Jean-Louis Teboul; Mervyn Singer; Monica Rocco; Giorgio Conti; Leonardo De Luca; Emanuele Di Angelantonio; Alessandra Orecchioni; Natesa G Pandian; Paolo Pietropaoli
Journal:  Intensive Care Med       Date:  2005-04-06       Impact factor: 17.440

5.  Estimation of left ventricular operating stiffness from Doppler early filling deceleration time in humans.

Authors:  M J Garcia; M S Firstenberg; N L Greenberg; N Smedira; L Rodriguez; D Prior; J D Thomas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-02       Impact factor: 4.733

Review 6.  Phospholamban: a promising therapeutic target in heart failure?

Authors:  A G Schmidt; I Edes; E G Kranias
Journal:  Cardiovasc Drugs Ther       Date:  2001-09       Impact factor: 3.727

7.  The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts.

Authors:  Matthias Behrends; Jürgen Peters
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

8.  Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis.

Authors:  Julien Charpentier; Charles-Edouard Luyt; Yvonne Fulla; Christophe Vinsonneau; Alain Cariou; Sophie Grabar; Jean-François Dhainaut; Jean-Paul Mira; Jean-Daniel Chiche
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

9.  Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.

Authors:  Damien Barraud; Valérie Faivre; Thibault Damy; Stéphane Welschbillig; Etienne Gayat; Christophe Heymes; Didier Payen; Ajay M Shah; Alexandre Mebazaa
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

Review 10.  Mechanisms of sepsis-induced cardiac dysfunction.

Authors:  Alain Rudiger; Mervyn Singer
Journal:  Crit Care Med       Date:  2007-06       Impact factor: 7.598

View more
  4 in total

Review 1.  Year in review 2009: Critical Care--shock.

Authors:  Wolfgang Stahl; Hendrik Bracht; Peter Radermacher; Jörg Thomas
Journal:  Crit Care       Date:  2010-11-05       Impact factor: 9.097

2.  Effects of inhibiting mTOR with rapamycin on behavior, development, neuromuscular physiology and cardiac function in larval Drosophila.

Authors:  Samuel Potter; Jacob Sifers; Emily Yocom; Sandra L E Blümich; Rachel Potter; Jeremy Nadolski; Douglas A Harrison; Robin L Cooper
Journal:  Biol Open       Date:  2019-11-21       Impact factor: 2.422

3.  Investigating PIK3R3 and ATp2A1 Genes Expressions in Ventilator-Associated Pneumonia Patients Admitted to the Intensive Care Unit of Masih Daneshvari Hospital in 2016.

Authors:  Hamidreza Jamaati; Naghmeh Bahrami; Mahya Daustany; Payam Tabarsi; Behrooz Farzanegan; Seyed Mohammadreza Hashemian; Abdolreza Mohamadnia
Journal:  Rep Biochem Mol Biol       Date:  2018-04

4.  Developing a gene expression model for predicting ventilator-associated pneumonia in trauma patients: a pilot study.

Authors:  Joseph M Swanson; G Christopher Wood; Lijing Xu; Lisa E Tang; Bernd Meibohm; Ramin Homayouni; Martin A Croce; Timothy C Fabian
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.